Igor Matushansky - Mar 21, 2025 Form 4 Insider Report for Immuneering Corp (IMRX)

Role
Chief Medical Officer
Signature
/s/ Michael D. Bookman, Attorney-in-Fact for Igor Matushansky
Stock symbol
IMRX
Transactions as of
Mar 21, 2025
Transactions value $
$0
Form type
4
Date filed
3/24/2025, 04:12 PM
Previous filing
Mar 24, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMRX Stock Option Award $0 +118K $0.00 118K Mar 21, 2025 Class A Common Stock 118K $1.80 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable as to 25% of the underlying shares on March 17, 2026 and then in equal monthly installments over the subsequent three years, subject to the reporting person's continued employment through each applicable vesting date.